The judge considering whether to grant a new trial after a jury returned a $9 billion verdict in the first federal Actos bellwether trial recently had several questions for the lawyers.
A jury awarded $9 billion, most of it in punitive damages, against Takeda Pharmaceuticals North America and Eli Lilly & Co in a case in which plaintiffs said they were not warned that using the diabetes drug increases their risk of bladder cancer. Lilly had an agreement to co-market the drug with Takeda.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
